PULSE NEWS WIRE
Clear, Actionable Intelligence
17,800+
Articles
4,436
Companies
2,300+
Exclusive to PNW
<2 min
To English
Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure from Mochida Pharmaceutical Co.,Ltd. was processed by Pulse News Wire on March 30, 2026. It represents a primary source document for Japanese M&A sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
TOKYO, Mar 30 (Pulse News Wire) – Mochida Pharmaceutical CO.,LTD. (4534.T) announced plans to sell its ordinary shares through Mitsubishi UFJ Morgan Stanley Securities. The offering involves up to 1,0